A post-hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus 100 U/mL (Gla-100) over wider nocturnal windows in individuals with type 2 diabetes on a basal-only insulin regimen-Reference-Cited by-同舟云学术

A post-hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus 100 U/mL (Gla-100) over wider nocturnal windows in individuals with type 2 diabetes on a basal-only insulin regimen

Published:2018-10-02 Issue:2 Volume:21 Page:402-407
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bolli Geremia B.¹^ORCID,Wysham Carol²,Fisher Miles³,Chevalier Soazig⁴,Cali Anna M. G.⁴,Leroy Bruno⁴,Riddle Matthew C.⁵^ORCID

Affiliation:

1. Department of Medicine; University of Perugia; Perugia Italy

2. Diabetes and Endocrinology Center; Rockwood Clinic; Spokane Washington

3. Glasgow Royal Infirmary; University of Glasgow; Glasgow UK

4. Sanofi; Paris France

5. Oregon Health and Science University; Portland Oregon

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13515/fullpdf

Reference16 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

2. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study;Peyrot;Diabet Med,2012

3. The impact of nocturnal hypoglycemia on clinical and cost-related issues in patients with type 1 and type 2 diabetes;Edelman;Diabetes Educ,2014

4. The past, present, and future of basal insulins;Pettus;Diabetes Metab Res Rev,2016

5. New insulin glargine 300 Units mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units . mL-1;Becker;Diabetes Care,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The physiological basis of insulin therapy in people with diabetes mellitus;Diabetes Research and Clinical Practice;2021-05

3. The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review;Diabetes Therapy;2020-09-25

4. Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials;Diabetes, Obesity and Metabolism;2020-07-21

5. Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project;BMJ Open;2020-04